-
Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Among Ticagrelor-Treated Patients With Bleeding or Undergoing Urgent Surgery in the United States: A Real-World, Retrospective Claims Analysis
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population
Mar 10, 2025, 14:00 PM -
Psychometric Evaluation of the ASCOT-SCT4, a Preference-Based Quality of Life Instrument for Social Care Service Users in Hong Kong: An Application of Item Response Theory
Mar 10, 2025, 14:00 PM -
Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Guatemala
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Follitropin Delta versus Follitropin Alfa in Controlled Ovarian Stimulation for IVF/ICSI Cycles in China
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Sociodemographic Factors on Patient Perceptions of Chronic Heart Failure Management
Mar 10, 2025, 14:00 PM -
A European perspective on Health Resource Utilization (HRU) and Cost outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Costs and Resource Optimization in the Rheumatoid Arthritis Care Pathway: A TDABC-Based Analysis in a Clinic in São Paulo
Mar 10, 2025, 14:00 PM -
Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain
Mar 10, 2025, 14:00 PM -
Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic
Mar 10, 2025, 14:00 PM -
Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE
Mar 10, 2025, 14:00 PM -
Leveraging AI/Technology in Survey Design, Deployment, and Analysis
Mar 10, 2025, 14:00 PM -
Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment and Prioritization Decisions
Mar 10, 2025, 14:00 PM -
Frailty Indices Using Claims Data - Examples from a Hospitalized Medicare Population
Mar 10, 2025, 14:00 PM -
Advancing Breast Cancer Research in Japan Using EHR-Derived Real-World Data
Mar 10, 2025, 14:00 PM -
Estimating the U.S. Economic Burden of Autoimmune Diseases: A Pilot Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Analysis of the Effect of Trofinetide Treatment on the Domain and Item-Level Responses of the Rett Syndrome Behavior Questionnaire Using Data From the LAVENDER Trial
Mar 10, 2025, 14:00 PM -
Temporal Trends in Prescription of GLP-1RAs for Weight Loss: Insights From a Five-Year Retrospective Analysis in the US
Mar 10, 2025, 14:00 PM -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents
Mar 10, 2025, 14:00 PM
